Zentalis Pharmaceuticals, Inc. (ZNTL)

Price & Market Data

Price: $3.98

Daily Change: -$0.16 / 4.02%

Daily Range: $3.98 - $4.33

Market Cap: $289,016,576

Daily Volume: 546,934

Performance Metrics

1 Week: 1.50%

1 Month: 0.25%

3 Months: 61.75%

6 Months: 212.3%

1 Year: 238.3%

YTD: 200.7%

About Zentalis Pharmaceuticals, Inc. (ZNTL)

Get the latest on Zentalis Pharmaceuticals, Inc. (ZNTL). Priced at 3.98, with a daily shift of -$0.16 / 4.02%. Market cap: 289,016,576. Crucial performance data includes YTD (200.7%) and 1-month (0.25%) returns.

Company Details

Employees: 106

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. It develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. The company also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is based in San Diego, California.

Selected stocks

Krispy Kreme, Inc. (DNUT)

Dolphin Entertainment, Inc. (DLPN)

Reed's, Inc. (REED)

Microbot Medical Inc. (MBOT)

Sprinklr, Inc. (CXM)